Leukoplakia Oral
9 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions (NCT03939364) | Skyline Biosciences | 2022-01-01 |
| Oral Potentially Malignant Disorders: Comparison Between Surgical Treatment and Wait and See Approach (NCT04858100) | University of Milan | 2020-09-01 |
| Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia (NCT03692325) | Dana-Farber Cancer Institute | 2018-12-05 |
| Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making (NCT03239834) | Vigilant Biosciences, Inc. | 2017-09-07 |
| Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity (NCT01636544) | Institut Pasteur | 2012-06-15 |
| A Randomized Study of Sulindac in Oral Premalignant Lesions (NCT00299195) | Memorial Sloan Kettering Cancer Center | 2006-02-23 |
Track Leukoplakia Oral automatically
Every clearance here is in the API, with alerts when new ones post.